Uqba Khan

The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma

Ambreen Muhammed, Claudia Angela Maria Fulgenzi, Sirish Dharmapuri et al. · Cancers · 2021 · 78 citations · Full text

Immunotherapy-associated autoimmune hemolytic anemia

Uqba Khan, Farman Ali, Muhammad Khurram et al. · Journal for ImmunoTherapy of Cancer · 2017 · 74 citations · Full text

Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade

David J. Pinato, Takahiro Kaneko, Anwaar Saeed et al. · Cancers · 2020 · 74 citations · Full text

Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study

Brett Marinelli, Edward Kim, Antonio D’Alessio et al. · Journal for ImmunoTherapy of Cancer · 2022 · 67 citations · Full text

Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice

David J. Pinato, Thomas U. Marron, Pallavi S. Mishra‐Kalyani et al. · European Journal of Cancer · 2021 · 62 citations

Hepatology, Landmark Clinical Trials, Medicine +12